A safety and efficacy preliminary clinical study of KQ-19B CAR-T cells for the treatment of relapse/refractory multiple myeloma

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2021
This article has no abstract
Epistemonikos ID: 6221452cb6265b3c18e81ee80e0fdab49796af5b
First added on: Apr 07, 2025